Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: One-month results of the Bioresorbable vascular Scaffold Evaluated at Rotterdam Cardiology Hospitals (B-SEARCH)

EuroIntervention

Volumn 10, Issue 2, 2014, Pages 236-240

  Simsek, Cihan ^a   Magro, Michael ^a   Onuma, Yoshinobu ^a   Boersma, Eric ^a   Smits, Peter ^b   Dorange, Cecile ^c   Veldhof, Susan ^c   Regar, Evelyn ^a   Serruys, Patrick W ^a   Van Geuns, Robert Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c ABBOTT VASCULAR   (United States)

Author keywords

Everolimus eluting bioresorbable vascular scaffold; Percutaneous coronary intervention

Indexed keywords

EVEROLIMUS; CARDIOVASCULAR AGENT; DRUG CARRIER; RAPAMYCIN;

ABSENCE OF COMPLICATIONS; ADULT; ANGINA PECTORIS; ARTICLE; BLOOD VESSEL DIAMETER; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE SAFETY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GUIDING CATHETER; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RECURRENT DISEASE; REVASCULARIZATION; AGED; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; ENDOSCOPIC ECHOGRAPHY; HOSPITAL; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PROSTHESIS; REGISTER; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG CARRIERS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSTHESIS DESIGN; REGISTRIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84905464967     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I2A38     Document Type: Article

References (8)

1. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108-11.
2. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435-41. (Pubitemid 46717966)
3. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. (Pubitemid 351384734)
4. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, García-García HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122:2301-12.
5. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004;109:190-5. (Pubitemid 38114138)
6. Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT. The unrestricted use of paclitaxel versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol. 2005;45:1135-41. (Pubitemid 40432449)
7. Onuma Y, Kukreja N, Piazza N, Eindhoven J, Girasis C, Schenkeveld L, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000 to 2007). The everolimus-eluting stent in real-world patients: 6 months follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. J Am Coll Cardiol. 2009;54:269-76.
8. Farooq V, Gomez-Lara J, Brugaletta S, Gogas BD, Garcìa- Garcìa HM, Onuma Y, van Geuns RJ, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW. Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study. Catheter Cardiovasc Interv. 2012;79:880-8.